Cargando…
MicroRNA-485-5p inhibits glioblastoma progression by suppressing E2F transcription factor 1 under cisplatin treatment
Cisplatin (CDDP) has been widely used for glioblastoma treatment. miR-485-5p and E2F transcription factor 1 (E2F1) dysfunction has been reported in glioblastoma. Nonetheless, whether CDDP affects glioblastoma progression via the miR-485-5p-E2F1 axis requires investigation. The expression of miR-485-...
Autores principales: | Huang, Conggang, Ma, Lan, Duan, Faliang, Li, Ruixue, Zhang, Yanguo, Wang, Yuan, Luo, Ming, He, Zhuqiang, Luo, Zhihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806419/ https://www.ncbi.nlm.nih.gov/pubmed/34726120 http://dx.doi.org/10.1080/21655979.2021.1982269 |
Ejemplares similares
-
Analysis of the effects of stent-induced deformation on the hemodynamics of MCA aneurysms
por: Huang, Conggang, et al.
Publicado: (2023) -
MicroRNA-485 plays tumour-suppressive roles in colorectal cancer by directly targeting GAB2
por: Li, Jibin, et al.
Publicado: (2022) -
Targeting MicroRNA-485-3p Blocks Alzheimer’s Disease Progression
por: Koh, Han Seok, et al.
Publicado: (2021) -
LINC00488 stimulates the progression of esophageal cancer by targeting microRNA-485-5p
por: Xu, Hongbo, et al.
Publicado: (2021) -
microRNA-485 inhibits the malignant behaviors of retinoblastoma by directly targeting Wnt3a
por: Lyu, Xueman, et al.
Publicado: (2022)